Hussein, Mohammed Salah and AlOrainy, Walid Hajaj and Daghriri, Abdullah Mohammed and Alotaibi, Khalid Mohammed and Alanazi, Afnan Hamdan Owayn and Alkhathlan, Husam Abdulaziz and Alsaaedi, Raghad Abdullah and Alamoudi, Najd Adnan and Talib, Faisal Abdulmohsen Bin and Al Ali, Muzaynah Abdullah and Alowaidi, Mohammed Abdullatif and Alshammari, Naif salem H and Mujarribi, Laila Mohammed and Almalki, Rayan Saad Ahmed and Oraijah, Afnan Abdullah Ahmed (2021) Epidemiology and Management of Unconjugated Hyperbilirubinemia. Journal of Pharmaceutical Research International, 33 (60B). pp. 1337-1345. ISSN 2456-9119
6808-Article Text-9227-2-10-20221006.pdf - Published Version
Download (480kB)
Abstract
Unconjugated hyperbilirubinemia is characterised by increased serum or plasma bilirubin (unconjugated) levels that exceed the laboratory's reference range. Unconjugated hyperbilirubinemia, is the most common cause of jaundice in newborns. Unconjugated hyperbilirubinemia is caused by bilirubin metabolism dysregulation, which includes increased synthesis, reduced hepatic absorption, and decreased bilirubin conjugation. Gilbert syndrome (type 1 and 2), Crigler-Najjar syndromes (type 1 and 2), and hereditary illnesses producing hemolytic anaemia are all examples of inherited conditions that can cause unconjugated hyperbilirubinemia. Crigler-Najjar syndrome is a sporadic condition, Gilbert syndrome is more common yet less dangerous symptom. Using phototherapy and plasmapheresis, the major goal of treatment is to lower the amount of unconjugated bilirubin. Intensive phototherapy is the basis of management of Crigler-Najjar syndrome type 1. Combined with plasmapheresis and in some cases liver transplantation may be required.
Item Type: | Article |
---|---|
Subjects: | Open Article Repository > Medical Science |
Depositing User: | Unnamed user with email support@openarticledepository.com |
Date Deposited: | 10 Mar 2023 07:30 |
Last Modified: | 09 Jul 2024 07:01 |
URI: | http://journal.251news.co.in/id/eprint/337 |